Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cryoport, a cryogenic logistics company, has announced that it will be supporting the cryogenic logistics requirements of ImmunoCellular Therapeutics' registrational Phase III glioblastoma clinical trial across 120 sites in North America and Europe.
read more
Cryoport, a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences industry, with focus on the bio-pharmaceutical and cell and gene therapy markets, confirms that the Company does not have any ...
read more
Cryoport has announced the launch of its bio-storage offering. The new offering is the result of a clear demand from Cryoport customers to complement its cryogenic logistics solutions with advanced storage and fulfillment capabilities.
read more
Monday, September 12, 2022
Cryoport has entered into a strategic relationship with BioLife Plasma Services, part of the global biopharmaceutical company Takeda, intended to provide consistent, high-quality cellular starting material for use in the manufacture of life-saving ...
read more
Cryoport announced it will assist Sanaria in the design and implementation of the cryogenic cold chain for Sanaria’s investigational malaria vaccines.
read more
Cryoport, Inc. has announced that its wholly owned operating companies, Cryoport Systems and CRYOPDP, have jointly opened a new Global Logistics Center in Singapore.
read more
Tuesday, December 01, 2015
Cryoport, a cryogenic logistics company has been selected by QPS Hepatic Biosciences, a subsidiary of QPS Holdings LLC, as its cryogenic logistics partner supporting QPS's cryopreserved hepatocytes businesses in the USA and the EU, further augmenting...
read more
Friday, September 20, 2019
Cryoport announced the launch of its Advanced Therapy Shipper™ product line for the regenerative medicine market.
read more
The Cryoport. Certified. Cool. solution is designed to provide cold-chain logistics in the 2 – 8 degrees Celsius temperature range for regenerative therapy requirements.
read more
Tuesday, February 28, 2017
The Cryoport Biotech Regenerative Therapy Activity Index (the "CoBRA IndexSM") quantifies the activity in the development and clinical trials of regenerative therapies in the United States, and acts as a means by which investors, the media and ...
read more
Cryoport, Inc. a temperature-controlled logistics company serving the life sciences industry, has initiated a novel and comprehensive logistics study to evaluate the impact of temperature and transport packaging at deep frozen temperatures on ...
read more
Cryoport and Medipal Holdings announced a multi-year strategic business alliance agreement to create an integrated regenerative medicine supply chain solution in Japan.
read more
Thursday, February 10, 2022
Cryoport, Inc. has provided an update on resumption of activities at the New Prague facility. As previously announced, a fire occurred in a portion of the MVE Biological Solutions manufacturing facility located in New Prague, Minnesota on January 25,...
read more
Cryoport announced financial results for the first quarter ended March 31, 2017.
read more
Cryoport, Inc. has signed a new three-year supply chain solutions agreement with Monash IVF Group Limited, a provider of assisted reproductive services, as well as specialist women’s imaging and diagnostic services in Australia and Southeast Asia.
read more